The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix

Aim: Villoglandular adenocarcinoma (VGA) of the uterine cervix is a variant of endocervical adenocarcinoma. However, the clinicopathologic and immunohistochemical features of VGA are still unclear. The aim of this study was to investigate the clinicopathologic and immunohistochemical features of VGA...

Full description

Bibliographic Details
Main Authors: Zhuo-Ya Huang, Sisi Zhang, Yao-Zhong Zhang, Jian-Hong An, Jiao Luo, Peng-Juan Liao, Qing Chen, Hong Shen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=4;spage=549;epage=552;aulast=Huang
id doaj-4ccbbd70741b41eab1aa646bce6a5785
record_format Article
spelling doaj-4ccbbd70741b41eab1aa646bce6a57852020-11-24T21:50:06ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292018-01-0161454955210.4103/IJPM.IJPM_144_18The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervixZhuo-Ya HuangSisi ZhangYao-Zhong ZhangJian-Hong AnJiao LuoPeng-Juan LiaoQing ChenHong ShenAim: Villoglandular adenocarcinoma (VGA) of the uterine cervix is a variant of endocervical adenocarcinoma. However, the clinicopathologic and immunohistochemical features of VGA are still unclear. The aim of this study was to investigate the clinicopathologic and immunohistochemical features of VGA. Materials and Methods: A total of 20 VGA patients were identified among 852 patients diagnosed with cervical cancer and enrolled in this study. The immunohistochemical levels of Ki-67, P53, P16, progesterone receptor (PR), carcinoembryonic antigen (CEA), vimentin (Vim), and estrogen receptor (ER) were measured by immunohistochemistry. Results: VGA was prevalent in younger women and presented favorable prognosis. Ki-67, P16, and CEA were highly expressed in VGA tissues, while PR expression was hardly to be detected. The positive rates of Ki-67, CEA, and P16 were 90.0%, 90.0%, and 85.0%, respectively, which were significantly higher compared with PR (5.0%, P < 0.001). In addition, the positive rates of P53, Vim, and ER in VGA tissues were 55.0%, 50.0%, and 40.0%, respectively. However, the expression levels of Ki-67, P53, P16, PR, CEA, Vim, and ER were not significantly associated with clinical features (P > 0.05). Conclusion: These data indicate that VGA is a rare cervical adenocarcinoma, which is prevalent in younger women, and presents favorable prognosis. Detection of Ki-67, P53, P16, PR, CEA, Vim, and ER would be beneficial for the diagnosis of VGA.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=4;spage=549;epage=552;aulast=HuangClinical stageclinicopathologic featurehuman papillomavirus infectionsoutcomevilloglandular adenocarcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Zhuo-Ya Huang
Sisi Zhang
Yao-Zhong Zhang
Jian-Hong An
Jiao Luo
Peng-Juan Liao
Qing Chen
Hong Shen
spellingShingle Zhuo-Ya Huang
Sisi Zhang
Yao-Zhong Zhang
Jian-Hong An
Jiao Luo
Peng-Juan Liao
Qing Chen
Hong Shen
The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix
Indian Journal of Pathology and Microbiology
Clinical stage
clinicopathologic feature
human papillomavirus infections
outcome
villoglandular adenocarcinoma
author_facet Zhuo-Ya Huang
Sisi Zhang
Yao-Zhong Zhang
Jian-Hong An
Jiao Luo
Peng-Juan Liao
Qing Chen
Hong Shen
author_sort Zhuo-Ya Huang
title The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix
title_short The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix
title_full The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix
title_fullStr The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix
title_full_unstemmed The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix
title_sort clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Pathology and Microbiology
issn 0377-4929
publishDate 2018-01-01
description Aim: Villoglandular adenocarcinoma (VGA) of the uterine cervix is a variant of endocervical adenocarcinoma. However, the clinicopathologic and immunohistochemical features of VGA are still unclear. The aim of this study was to investigate the clinicopathologic and immunohistochemical features of VGA. Materials and Methods: A total of 20 VGA patients were identified among 852 patients diagnosed with cervical cancer and enrolled in this study. The immunohistochemical levels of Ki-67, P53, P16, progesterone receptor (PR), carcinoembryonic antigen (CEA), vimentin (Vim), and estrogen receptor (ER) were measured by immunohistochemistry. Results: VGA was prevalent in younger women and presented favorable prognosis. Ki-67, P16, and CEA were highly expressed in VGA tissues, while PR expression was hardly to be detected. The positive rates of Ki-67, CEA, and P16 were 90.0%, 90.0%, and 85.0%, respectively, which were significantly higher compared with PR (5.0%, P < 0.001). In addition, the positive rates of P53, Vim, and ER in VGA tissues were 55.0%, 50.0%, and 40.0%, respectively. However, the expression levels of Ki-67, P53, P16, PR, CEA, Vim, and ER were not significantly associated with clinical features (P > 0.05). Conclusion: These data indicate that VGA is a rare cervical adenocarcinoma, which is prevalent in younger women, and presents favorable prognosis. Detection of Ki-67, P53, P16, PR, CEA, Vim, and ER would be beneficial for the diagnosis of VGA.
topic Clinical stage
clinicopathologic feature
human papillomavirus infections
outcome
villoglandular adenocarcinoma
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=4;spage=549;epage=552;aulast=Huang
work_keys_str_mv AT zhuoyahuang theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT sisizhang theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT yaozhongzhang theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT jianhongan theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT jiaoluo theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT pengjuanliao theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT qingchen theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT hongshen theclinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT zhuoyahuang clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT sisizhang clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT yaozhongzhang clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT jianhongan clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT jiaoluo clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT pengjuanliao clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT qingchen clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
AT hongshen clinicopathologicandimmunohistochemicalfeaturesofvilloglandularadenocarcinomaofuterinecervix
_version_ 1725885256488189952